Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older
- You have been diagnosed with non-small cell lung cancer that has not spread to other parts of the body, and your tumor shows a certain protein marker (called PD-L1) at a level of 1% or higher
- Your doctor has already decided, as part of your normal care, to treat you with a combination of a drug called nivolumab and chemotherapy containing platinum before surgery
- You are willing to fill out questionnaires about how you are feeling during the trial, and you have a good enough understanding of the German language to do so
- You have read and signed a form agreeing to take part in the study
- You meet any additional medical requirements listed in the official product information for this medication (confirm with trial site)
Who may not be able to join:
- You currently have another type of cancer (other than non-small cell lung cancer) that needs treatment, such as medication or other therapies
- You have any other medical reasons why you should not take this medication, as outlined in the official product information (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Event-free survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.